Large-scale testing (Phase 3)Study completedNCT03581591
What this trial is testing
Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic Rickets
Who this might be right for
HypophosphatemiaHypophosphatemic RicketsPain, Chronic
Redwood Dermatology Sciences 1